FI884003A0 - NYA PYRIDYLETHANOLAMINER, DESSA FOERENINGAR INNEHAOLLANDE LAEKEMEDEL OCH FOERFARANDE FOER DERAS FRAMSTAELLNING. - Google Patents
NYA PYRIDYLETHANOLAMINER, DESSA FOERENINGAR INNEHAOLLANDE LAEKEMEDEL OCH FOERFARANDE FOER DERAS FRAMSTAELLNING.Info
- Publication number
- FI884003A0 FI884003A0 FI884003A FI884003A FI884003A0 FI 884003 A0 FI884003 A0 FI 884003A0 FI 884003 A FI884003 A FI 884003A FI 884003 A FI884003 A FI 884003A FI 884003 A0 FI884003 A0 FI 884003A0
- Authority
- FI
- Finland
- Prior art keywords
- pyridylethanolaminer
- nya
- foerfarande foer
- acid addition
- addition salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Hydrogenated Pyridines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Pyridylethanolamines of the formula <IMAGE> in which R denotes a carboxymethoxy, carbomethoxymethoxy, ethoxycarbonylmethoxy or 2-hydroxyethoxy group, their optical isomers, their diastereomers and their acid addition salts. The novel compounds of the above formula I, their optical isomers and their diastereomers and also their acid addition salts, in particular their physiologically tolerable acid addition salts with inorganic or organic acids, have useful pharmacological properties, namely an effect on the metabolism, preferably a hypoglycaemic and body fat-reducing effect, and also a lowering effect on the atherogenic beta -lipoproteins VLDL and LDL. The novel compounds of the above formula I can be prepared by processes which are known per se.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19873729284 DE3729284A1 (en) | 1987-09-02 | 1987-09-02 | NEW HETEROARYLETHANOLAMINES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
Publications (2)
Publication Number | Publication Date |
---|---|
FI884003A0 true FI884003A0 (en) | 1988-08-31 |
FI884003A FI884003A (en) | 1989-03-03 |
Family
ID=6335037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI884003A FI884003A (en) | 1987-09-02 | 1988-08-31 | NYA PYRIDYLETHANOLAMINER, DESSA FOERENINGAR INNEHAOLLANDE LAEKEMEDEL OCH FOERFARANDE FOER DERAS FRAMSTAELLNING. |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0305845B1 (en) |
JP (1) | JPH0196172A (en) |
KR (1) | KR890005056A (en) |
AT (1) | ATE81851T1 (en) |
AU (1) | AU617353B2 (en) |
CA (1) | CA1331005C (en) |
DE (2) | DE3729284A1 (en) |
DK (1) | DK486988A (en) |
FI (1) | FI884003A (en) |
IL (1) | IL87620A0 (en) |
NZ (1) | NZ226006A (en) |
PT (1) | PT88392B (en) |
ZA (1) | ZA886501B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4918086A (en) * | 1987-08-07 | 1990-04-17 | Ciba-Geigy Corporation | 1-nitro-2,2-diaminoethylene derivatives |
DE4006794A1 (en) * | 1990-03-03 | 1991-09-05 | Bayer Ag | METHOD FOR PRODUCING AMINOETHANOL DERIVATIVES |
AU2003248614B2 (en) * | 2002-07-17 | 2007-08-30 | Lek Pharmaceuticals D.D. | Novel derivatives of pyridylethanol (phenylethyl) amines as inhibitors of cholesterol biosynthesis, processes for their preparation, and pharmaceutical compositions containing them |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3615293A1 (en) * | 1986-05-06 | 1987-11-12 | Bayer Ag | USE OF HETEROARYLETHYLAMINE FOR PERFORMANCE IN ANIMALS, HETEROARYLETHYLAMINE AND METHOD FOR THE PRODUCTION THEREOF |
CA1287061C (en) * | 1986-06-27 | 1991-07-30 | Roche Holding Ltd. | Pyridine ethanolamine derivatives |
DE3627663A1 (en) * | 1986-08-14 | 1988-03-03 | Bayer Ag | HETEROARYLETHYLAMINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A PERFORMANCE IN ANIMALS |
EP0281841B1 (en) * | 1987-03-07 | 1990-11-14 | Bayer Ag | Process for preparation of 5-amino-4,6-dihalogenopyridines |
-
1987
- 1987-09-02 DE DE19873729284 patent/DE3729284A1/en not_active Withdrawn
-
1988
- 1988-08-22 DE DE8888113612T patent/DE3875563D1/en not_active Expired - Lifetime
- 1988-08-22 AT AT88113612T patent/ATE81851T1/en not_active IP Right Cessation
- 1988-08-22 EP EP88113612A patent/EP0305845B1/en not_active Expired - Lifetime
- 1988-08-31 CA CA000576154A patent/CA1331005C/en not_active Expired - Fee Related
- 1988-08-31 NZ NZ226006A patent/NZ226006A/en unknown
- 1988-08-31 FI FI884003A patent/FI884003A/en not_active Application Discontinuation
- 1988-08-31 IL IL87620A patent/IL87620A0/en unknown
- 1988-09-01 KR KR1019880011275A patent/KR890005056A/en not_active Application Discontinuation
- 1988-09-01 DK DK486988A patent/DK486988A/en not_active Application Discontinuation
- 1988-09-01 AU AU21790/88A patent/AU617353B2/en not_active Ceased
- 1988-09-01 ZA ZA1988/06501A patent/ZA886501B/en unknown
- 1988-09-01 PT PT88392A patent/PT88392B/en not_active IP Right Cessation
- 1988-09-01 JP JP63219623A patent/JPH0196172A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
DE3875563D1 (en) | 1992-12-03 |
DK486988A (en) | 1989-03-03 |
CA1331005C (en) | 1994-07-26 |
PT88392B (en) | 1992-10-30 |
KR890005056A (en) | 1989-05-11 |
ZA886501B (en) | 2008-05-30 |
JPH0196172A (en) | 1989-04-14 |
ATE81851T1 (en) | 1992-11-15 |
DE3729284A1 (en) | 1989-03-23 |
AU617353B2 (en) | 1991-11-28 |
EP0305845A1 (en) | 1989-03-08 |
PT88392A (en) | 1989-07-31 |
DK486988D0 (en) | 1988-09-01 |
IL87620A0 (en) | 1989-01-31 |
NZ226006A (en) | 1991-05-28 |
EP0305845B1 (en) | 1992-10-28 |
FI884003A (en) | 1989-03-03 |
AU2179088A (en) | 1989-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0742209A3 (en) | A process for producing an optically active quinolinemevalonolactone and a process for producing an optically active quinolinemevalonic acid salt | |
FR2564859B1 (en) | PROCESS FOR THE PREPARATION OF HYALURONIC ACID BY FERMENTATION. | |
ES2127765T3 (en) | PROCEDURE FOR THE SEPARATION OF 5-METHYL-TETRAHYDROPHOLIC ACID. | |
ATE158798T1 (en) | METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLOBUTANE NUCLEOSIDES | |
PT80820B (en) | METHOD FOR PREPARING DERIVATIVES OF 2-SUBSTITUTED 1,3-PROPYLIDENODPHOSPHONATE | |
SE8600017D0 (en) | NEW COMPOUND | |
PL263885A1 (en) | Method of obtaining novel derivatives of dihydrobenzofurane and chromate carbonamide | |
FI884003A0 (en) | NYA PYRIDYLETHANOLAMINER, DESSA FOERENINGAR INNEHAOLLANDE LAEKEMEDEL OCH FOERFARANDE FOER DERAS FRAMSTAELLNING. | |
YU47973B (en) | S-ENANTIOMERIC GLUTARAMIDES AND THE PROCEDURE FOR OBTAINING THEM | |
FI864970A (en) | NYA KRISTALLINA SALTER AV ARYLOXI-PROPANOLAMINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING. | |
FI870176A (en) | NYA FOERENINGAR OCH DERAS FRAMSTAELLNINGSFOERFARANDEN. | |
DE59107451D1 (en) | Process for the production of crystalline TACS | |
SE8803765L (en) | NEW ISOPOLYPEPTIDES AND PROCEDURES FOR THE PREPARATION OF THE SAME | |
DK643189D0 (en) | PREPARATION OF 5-ACYLAMINO-1,2,4-TRIAZOL-3-SULPHONAMIDES AND INTERMEDIATES | |
MA21305A1 (en) | PROCESS FOR THE PREPARATION OF ACID (PYRIDYL-3) -3 IH, 3H-PYRRONO (I, 2-C) THIAZOLECARBOXYLIQUE-7 DEXTROCYRE. | |
ZA88640B (en) | Novel imidazo-and triazolothiadiazines,a process for the preparation thereof,medicaments containing same,and the use thereof,and some intermediates formed in the preparation of the compounds mentioned | |
ATA214393A (en) | PROCESS FOR THE PREPARATION OF 7-AMINO-3-CEPHEM-4-CARBONIC ACID DERIVATIVES | |
HU9302786D0 (en) | New thiophene-2-carboxylic acid derivatives and process for preparing them | |
EP0429751A3 (en) | Substituted 3-amino-sydnonimines, process for their preparation and their use | |
PT90831A (en) | PROCESS FOR THE PREPARATION OF 2-AMINO-7-HYDROXYETRALIN ETERES | |
ATE71616T1 (en) | PROCESS FOR THE MANUFACTURE OF E/Z MIXTURES OF 2-(BICYCLO(3.3.0>OCTAN-3-YLIDENE)ACETIG|UREDERIVATIVES WITH A MAJOR E OR Z CONTENT. | |
DE59703279D1 (en) | Production of an epoxy | |
HUT55774A (en) | Process for producing 13,14-dihydro-berbane derivatives and pharmaceutical compositions containing them | |
OA08918A (en) | Process for the enrichment of canallite by flotation. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |
Owner name: DR. KARL THOMAE GESELLSCHAFT MIT |